Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria

NCT03190694 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Diseases
Proteinuria

Interventions

DRUG: Dapagliflozin 10mg

Sponsor

Hiddo Lambers Heerspink

Collaborators

[object Object]